PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2104619
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2104619
Plasmid Purification market size was valued at US$ 2,190.8 Million in 2025, expanding at a CAGR of 12.6% from 2026 to 2033.
Purification of plasmid is defined as the process of isolating the plasmid DNA from proteins, ribosomes, genomic DNA, and cell walls of the bacteria cell. The increase in the demand for plasma production technology due to the fast growth in the production of pDNA in the field of gene therapy, vaccines, and non-viral vectors having some advantages over viral vectors has made a boom in the requirement for plasmid DNA purification. The production of recombinant proteins that are widely used in the biopharmaceutical and biotechnological industries can be seen as a mode of plasmid selection since the process of plasmid selection is involved in drug manufacturing, vaccines, and enzyme production. Thus, to meet these increasing production demands, plasmid purification technologies.
Plasmid Purification Market- Market Dynamics
Growing Adoption of Gene and Cell Therapies to Drive Market Growth
The rising prominence of gene and cell therapies is driving the Plasmid Purification market because high-purity plasmid DNA is a critical raw material used for the safe and efficient development and manufacturing of advanced therapeutic products. For example, by 2025, produced by the BioIndustry Association (BIA), cell and gene therapy will be one of the main centers of innovation in the UK, where, as a result of more than doubling of its workforce devoted to research and manufacturing-from 3,033 in the last three years to 6,232 in 2025, with plans to reach 10,000 in 2028-it is estimated that over 2,000 dedicated staff members will be involved in manufacturing, and over the next ten years, usage of advanced cell and gene therapies in the four major areas will bring more than USD 27,000 million in healthcare benefits to the country. This information demonstrates the increasing importance of cell and gene therapies in the UK.
The Global Plasmid Purification market is segmented on the basis of Product & Service, Grade, Application, End Use, and Region.
The Research Grade has captured the largest market share in the plasmid purification market on account of its increasing use in molecular biology research, gene cloning, PCR, DNA sequencing, synthetic biology, and other laboratory operations in research institutes and R&D of biopharmaceutical companies. The Research Grade is also benefitted due to high volume of research activities and use of plasmids in experiments. In June 2026, Thermo Fisher Scientific launched its new line of GeneJET(TM) and Invitrogen(TM) plasmid purification kit products which are research grade and enhance automation, yield and efficiency of work flow in molecular biology applications.
GMP Grade is anticipated to be the fastest growing grade of the market during the forecast period on account of rapid development of cell and gene therapies, DNA vaccines and mRNA. In April 2026, Cytiva announced the expansion of its plasmid DNA manufacturing capacity through new GMP grade bioprocessing solutions.
Plasmid Purification Market- Geographical Insights
North America accounts for a substantial share in the plasmid purification industry because of constant developments in molecular cloning research and development in the technology for purification processes and biotechnology capabilities within the region. For instance, according to the peer-reviewed study published in the National Center for Biotechnology Information (NCBI), innovations in the area of molecular cloning technologies like high-throughput DNA assembly, automation, and CRISPR-based molecular cloning technology have enhanced studies on the genome. Furthermore, the scientific industry in Canada gets an annual total grant and awards expenditure of CAD 1.33 billion from the Canadian Institutes of Health Research (CIHR). These advancements continue to strengthen North America's leadership in the global plasmid purification market.
India Plasmid Purification Market- Country Insights
The Indian government has been continually making progress in research on biotechnology by investing heavily and having favorable policies that promote innovation in the sector. For example, in December 2025, from the Press Information Bureau (PIB) of the Government of India, it was reported that the government is improving its biotechnology research using its BioE3 policy and Bio-RIDE programs meant to support innovation-driven research, sustainable biomanufacturing, and industrial collaboration. The investment being made towards this program totals USD 1,100 million and is geared towards fostering R&D in biotechnology and promoting bio-control innovations. Through this, India will become a center for biotechnology in the world, hence promoting long-term growth in the market.
The competitive landscape in the Plasmid Purification market is fragmented, and major stakeholders are concentrating on innovation and product development as well as collaborations as the product lines and product pipelines of the companies continue to grow, driven by increased demand for life science research, biopharmaceutical production, and molecular biology applications. In April 2025, QIAGEN unveiled its latest product range, which will consist of three new sample preparation systems, including the QIAsymphony Connect, to improve laboratory automation as well as nucleic acid and plasmid purification procedures in both molecular biology and genomics research. This will result in innovations and competitions in the plasmid purification industry.
In September 2025, Promega Corporation released two new methods for the isolation of nucleic acids. These products provide improvements in research and biopharmaceutical laboratories and are designed to ensure rapid, reproducible, and automated plasmid DNA isolation.